BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 27168397)

  • 1. Doses effects of zoledronic acid on mineral apatite and collagen quality of newly-formed bone in the rat's calvaria defect.
    Olejnik C; Falgayrac G; During A; Cortet B; Penel G
    Bone; 2016 Aug; 89():32-39. PubMed ID: 27168397
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Bolus or weekly zoledronic acid administration does not delay endochondral fracture repair but weekly dosing enhances delays in hard callus remodeling.
    McDonald MM; Dulai S; Godfrey C; Amanat N; Sztynda T; Little DG
    Bone; 2008 Oct; 43(4):653-62. PubMed ID: 18582604
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Optimal timing of a single dose of zoledronic acid to increase strength in rat fracture repair.
    Amanat N; McDonald M; Godfrey C; Bilston L; Little D
    J Bone Miner Res; 2007 Jun; 22(6):867-76. PubMed ID: 17371160
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Influence of early zoledronic acid administration on bone marrow fat in ovariectomized rats.
    Li GW; Xu Z; Chang SX; Zhou L; Wang XY; Nian H; Shi X
    Endocrinology; 2014 Dec; 155(12):4731-8. PubMed ID: 25243855
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of zoledronic acid in an L6-L7 rabbit spine fusion model.
    Bransford R; Goergens E; Briody J; Amanat N; Cree A; Little D
    Eur Spine J; 2007 Apr; 16(4):557-62. PubMed ID: 16967298
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparison of the Effects of Local and Systemic Zoledronic Acid Application on Mandibular Distraction Osteogenesis.
    Dundar S; Artas G; Acikan I; Yaman F; Kirtay M; Ozupek MF; Asutay F; Kom M
    J Craniofac Surg; 2017 Oct; 28(7):e621-e625. PubMed ID: 28708644
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Histomorphometric evaluation of the effects of zoledronic acid on mandibular distraction osteogenesis in rabbits.
    Pampu AA; Dolanmaz D; Tüz HH; Avunduk MC; Kişnişci RS
    J Oral Maxillofac Surg; 2008 May; 66(5):905-10. PubMed ID: 18423279
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Early inhibitory effects of zoledronic acid in tooth extraction sockets in dogs are negated by recombinant human bone morphogenetic protein.
    Gerard DA; Carlson ER; Gotcher JE; Pickett DO
    J Oral Maxillofac Surg; 2014 Jan; 72(1):61-6. PubMed ID: 23891015
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Matrix metalloproteinase-9 expression in alveolar extraction sockets of Zoledronic acid-treated rats.
    Basi DL; Hughes PJ; Thumbigere-Math V; Sabino M; Mariash A; Lunos SA; Jensen E; Gopalakrishnan R
    J Oral Maxillofac Surg; 2011 Nov; 69(11):2698-707. PubMed ID: 21752506
    [TBL] [Abstract][Full Text] [Related]  

  • 10. High-dose zoledronic acid impacts bone remodeling with effects on osteoblastic lineage and bone mechanical properties.
    Pozzi S; Vallet S; Mukherjee S; Cirstea D; Vaghela N; Santo L; Rosen E; Ikeda H; Okawa Y; Kiziltepe T; Schoonmaker J; Xie W; Hideshima T; Weller E; Bouxsein ML; Munshi NC; Anderson KC; Raje N
    Clin Cancer Res; 2009 Sep; 15(18):5829-39. PubMed ID: 19737962
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The inhibitory effect of zoledronate on early-stage osteoinduction by recombinant human bone morphogenetic protein 2 in an osteoporosis model.
    Lee JH; Baek HR; Lee KM; Zheng GB; Shin SJ; Jin YZ
    Growth Factors; 2015; 33(3):220-8. PubMed ID: 26099999
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Study on the effects of zoledronic-acid-loaded collagen membrane on bone metabolism cells].
    Meng YH; Peng Y; Liu D; Chen Y; Wang H; Liang X
    Zhonghua Kou Qiang Yi Xue Za Zhi; 2011 Feb; 46(2):107-11. PubMed ID: 21426781
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of Zoledronic Acid Application on Different Graft Materials in Calvarial Bone Defect Models. An Experimental Analysis.
    Koparal M; Gülsün B; Deveci E; Agacayak KS; Hamidi A
    Anal Quant Cytopathol Histpathol; 2016 Apr; 38(2):117-25. PubMed ID: 27386633
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Bone mineralization and vascularization in bisphosphonate-related osteonecrosis of the jaw: an experimental study in the rat.
    Kün-Darbois JD; Libouban H; Mabilleau G; Pascaretti-Grizon F; Chappard D
    Clin Oral Investig; 2018 Dec; 22(9):2997-3006. PubMed ID: 29453497
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Physicochemical, pharmacologic, and in vitro cellular effects of loading collagen membranes with zoledronic acid.
    Liao J; Meng Y; Zhai J; Wen C; Ten M; Tian A; Wang Y; Liang X
    Int J Oral Maxillofac Implants; 2013; 28(4):1027-36. PubMed ID: 23869361
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Manipulation of the anabolic and catabolic responses with OP-1 and zoledronic acid in a rat critical defect model.
    Little DG; McDonald M; Bransford R; Godfrey CB; Amanat N
    J Bone Miner Res; 2005 Nov; 20(11):2044-52. PubMed ID: 16234978
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Addition of bisphosphonate to antibiotic and anti-inflammatory treatment reduces bone resorption in experimental Staphylococcus aureus-induced arthritis.
    Verdrengh M; Carlsten H; Ohlsson C; Tarkowski A
    J Orthop Res; 2007 Mar; 25(3):304-10. PubMed ID: 17089391
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evaluation of Effects of Systemic Zoledronic Acid Application on Bone Maturation in the Consolidation Period in Distraction Osteogenesis.
    Akbulut Y; Gul M; Dundar S; Ozcan EC; Ozercan IH; Bozoglan A; Karasu N; Acikan I; Bingül MB
    J Craniofac Surg; 2021 Nov-Dec 01; 32(8):2901-2905. PubMed ID: 33935139
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Zoledronic acid in vivo increases in vitro proliferation of rat mesenchymal stromal cells.
    Heino TJ; Alm JJ; Halkosaari HJ; Välimäki VV
    Acta Orthop; 2016 Aug; 87(4):412-7. PubMed ID: 27196705
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Antitumor effects of clinical dosing regimens of bisphosphonates in experimental breast cancer bone metastasis.
    Daubiné F; Le Gall C; Gasser J; Green J; Clézardin P
    J Natl Cancer Inst; 2007 Feb; 99(4):322-30. PubMed ID: 17312309
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.